A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke

Atrial fibrillation in patients with ischaemic stroke in the Swedish national patient registers: how much do we miss?

(2014) Maria A. Baturova et al.   EUROPACE

Detection of Atrial Fibrillation After Ischemic Stroke or Transient Ischemic Attack

(2014) Amit Kishore et al.   STROKE

Risks for Stroke, Bleeding, and Death in Patients With Atrial Fibrillation Receiving Dabigatran or Warfarin in Relation to the CHADS_2 Score: A Subgroup Analysis of the RE-LY Trial

(2013) Jonas Oldgren   ANNALS OF INTERNAL MEDICINE

Screening for atrial fibrillation with baseline and intermittent ECG recording in an out-of-hospital population

(2013) Tijn Hendrikx et al.   BMC Cardiovascular Disorders

Improved Detection of Silent Atrial Fibrillation Using 72-Hour Holter ECG in Patients With Ischemic Stroke

(2013) Martin Grond et al.   STROKE

Screening to identify unknown atrial fibrillation

(2013) Nicole Lowres et al.   THROMBOSIS AND HAEMOSTASIS

Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation

(2012) Leif Friberg et al.   CIRCULATION

Improved screening for silent atrial fibrillation after ischaemic stroke

(2012) P. Doliwa Sobocinski et al.   EUROPACE

2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design: A report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society

(2012) H. Calkins et al.   EUROPACE

Population screening of 75- and 76-year-old men and women for silent atrial fibrillation (STROKESTOP)

(2012) Leif Friberg et al.   EUROPACE

Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden

(2012) Thomas Davidson et al.   EUROPEAN HEART JOURNAL

Comparative Effectiveness and Cost-Effectiveness of Computed Tomography Screening for Coronary Artery Calcium in Asymptomatic Individuals

(2011) Bob J.H. van Kempen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effectiveness and Cost-Effectiveness of Blood Pressure Screening in Adolescents in the United States

(2010) Y. Claire Wang et al.   JOURNAL OF PEDIATRICS

Newly Identified Events in the RE-LY Trial

(2010) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Enhanced Detection of Paroxysmal Atrial Fibrillation by Early and Prolonged Continuous Holter Monitoring in Patients With Cerebral Ischemia Presenting in Sinus Rhythm

(2010) Raoul Stahrenberg et al.   STROKE

Quality-Adjusted Life Expectancy (QALE) and Loss of QALE for Patients With Ischemic Stroke and Intracerebral Hemorrhage

(2010) Hsin-Yi Lee et al.   STROKE

Survival after stroke — The impact of CHADS2 score and atrial fibrillation

(2009) Karin M. Henriksson et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Dabigatran versus Warfarin in Patients with Atrial Fibrillation

(2009) Stuart J. Connolly et al.   NEW ENGLAND JOURNAL OF MEDICINE

Short-term ECG for out of hospital detection of silent atrial fibrillation episodes

(2008) Peter Sobocinski Doliwa et al.   SCANDINAVIAN CARDIOVASCULAR JOURNAL